Search results
Results from the WOW.Com Content Network
Anatomic lung resection, i.e. pulmonary lobectomy or pneumonectomy, in conjunction with removal of the lymph nodes from the mediastinum is the treatment modality that provides the greatest chance of long-term survival in patients with early stage non-small cell lung cancer.
Chemotherapy for NSCLC usually includes combination of two drugs (chemotherapy doublet), with one of the agents is cisplatin or carboplatin. In 2002, Schiller at al. published in the New England Journal of Medicine, a study that compared four chemotherapy regimens for advanced NSCLC, cisplatin and paclitaxel, cisplatin and gemcitabine, cisplatin and docetaxel, and carboplatin and paclitaxel. [14]
After the patient returns home they typically remain in recovery for about four to six weeks, although some patients may be able to return to work and normal activities sooner. [medical citation needed] Pain is very common amongst patients for quite some time after a lobectomy and doctors will usually prescribe pain medication to help with this ...
A sleeve lobectomy is a lobectomy that is coupled with the removal of a part of the main bronchus. The ends of the bronchus are then rejoined to reattach any remaining lung lobes. [27] This procedure is performed in lieu of pneumonectomy when surgeons determine the removal of the entire lung to be unnecessary for centrally located tumours. [22]
After diagnosis, further imaging and biopsies are done to determine the cancer's stage based on how far it has spread. Treatment for early stage lung cancer includes surgery to remove the tumor, sometimes followed by radiation therapy and chemotherapy to kill any remaining cancer cells. Later stage cancer is treated with radiation therapy and ...
Wilson, 74, revealed that she has finished chemotherapy treatments and is doing “absolutely fine,” nearly three months after announcing she’d been diagnosed with cancer and would take the ...
Adjuvant chemotherapy is given after a local treatment (radiotherapy or surgery). It can be used when there is little evidence of cancer present, but there is risk of recurrence. [6]: 55–59 It is also useful in killing any cancerous cells that have spread to other parts of the body.
For advanced (stage IV) and unresectable lung tumors, the first-line therapy is platinum-based doublet chemotherapy, combining cisplatin or carboplatin with another cytotoxic agent. [3] Regimens strongly depend on each patient performance status and response, and when the risk of adverse events could worsen quality of life significantly, basic ...